Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
Nathan Singh(Unknown), Marco Ruella(Parker Institute for Cancer Immunotherapy), Shunichiro Kuramitsu(University of Pennsylvania), Katharina E. Hayer(Children's Hospital of Philadelphia), Matthew D. Weitzman(Children's Hospital of Philadelphia), Xueqing Maggie Lu(Parker Institute for Cancer Immunotherapy), Seok Jae Hong(Parker Institute for Cancer Immunotherapy), Shelley L. Berger(University of Pennsylvania), Sangya Agarwal(Amgen (United States)), Pranali Ravikumar(Parker Institute for Cancer Immunotherapy), Saar Gill(Parker Institute for Cancer Immunotherapy), Charly R. Good(University of Pennsylvania), Shannon L. Maude(Children's Hospital of Philadelphia), Karen Thudium Mueller(Unknown), Olga Shestova(University of Pennsylvania), Ophir Shalem(Children's Hospital of Philadelphia), Stephan A. Grupp(Children's Hospital of Philadelphia), Raymone Pajarillo(Hospital of the University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Yong Gu Lee(Parker Institute for Cancer Immunotherapy), Elena J. Orlando, Carl H. June(University of Pennsylvania)
Cited by 297
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799